• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
NOX 11/12/18 0 197
11/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  197 
NOX
News: NOX Noxopharm Says Co's Darrt-1 Clinical Study Has Been Approved To Move To Its Final Stage
11/12/18 0 110
11/12/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  110 
NOX
Serindipity
08/12/18 4 1.2K
08/12/18 Last post  harvett Comments Created with Sketch.  4  Views Created with Sketch.  1.2K 
NOX
If the hat fits ...
30/11/18 2 893
30/11/18 Last post  smithy169 Comments Created with Sketch.  2  Views Created with Sketch.  893 
NOX 29/11/18 3 679
29/11/18 Last post  harvett Comments Created with Sketch.  3  Views Created with Sketch.  679 
NOX
AGM Recollections
28/11/18 8 1.7K
28/11/18 Last post  smithy169 Comments Created with Sketch.  8  Views Created with Sketch.  1.7K 
NOX
AGM report
23/11/18 10 1.3K
23/11/18 Last post  Roger10 Comments Created with Sketch.  10  Views Created with Sketch.  1.3K 

See All Discussions arrow Created with Sketch.

Timeline

DARRT-1 study advancing on basis of positive clinical data
11 Dec 09:06
 
NOX announces Positive Data from CEP-1 Study of Veyonda
29 Nov 09:59
 
Initial Director's Interest Notice
21 Nov 14:28
 
Results of Meeting
21 Nov 14:26
 
Appointment of Mr John Moore as Non-Executive Director
21 Nov 12:28
 
NOX 2018 AGM Presentations
21 Nov 10:57
 
View More arrow Created with Sketch.
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.